Magnetic Resonance Evaluation of Brain Metastases From Systemic Malignances With Two Doses of Gadobutrol 1.0 M Compared With Gadoteridol-Reference-Cited by-同舟云学术

Magnetic Resonance Evaluation of Brain Metastases From Systemic Malignances With Two Doses of Gadobutrol 1.0 M Compared With Gadoteridol

Published:2011-07 Issue:7 Volume:46 Page:411-418
ISSN:0020-9996
Container-title:Investigative Radiology
language:en
Short-container-title:Investigative Radiology

Author:

Katakami Nobuyuki,Inaba Yoshitaka,Sugata Shigenori,Tsurusaki Masakatsu,Itoh Takashi,Machida Toru,Tanaka Hisashi,Nakayama Tetsuo,Morikawa Tsutomu,Breuer Josy,Aitoku Yasuko

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference25 articles.

1. Central Nervous System: Review of Clinical Use of Contrast Media

2. Principles of contrast enhancement in the evaluation of brain diseases: An overview

3. Stereotactic radiosurgery for the treatment of brain metastases

4. Radiosurgery for metastatic brain tumors

5. Gamma knife surgery for brain metastases in patients harboring four or more lesions: survival and prognostic factors

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving Characteristics of Gadolinium‐Based Contrast Agents for MR Imaging: A Systematic Review of the Importance of Relaxivity;Journal of Magnetic Resonance Imaging;2024-05-03

2. Signal Enhancement and Enhancement Kinetics of Gadobutrol, Gadoteridol, and Gadoterate Meglumine in Various Body Regions;Investigative Radiology;2020-06

3. Performance of single-use syringe versus multi-use MR contrast injectors: a prospective comparative study;Scientific Reports;2020-03-03

4. Dose Finding Study of Gadopiclenol, a New Macrocyclic Contrast Agent, in MRI of Central Nervous System;Investigative Radiology;2020-03

5. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases;Neuro-Oncology;2020-02-12